A Regimen with Caplacizumab, Immunosuppression, and Plasma Exchange Prevents Unfavorable Outcomes in Immune-Mediated TTP.
Paul Coppo,Michael Bubenheim,Elie Azoulay,Lionel Galicier,Sandrine Malot,Naike Bige,Pascale Poullin,Francois Provot,Nihal Martis,Claire Presne,Olivier Moranne,Ruben Benainous,Antoine Dossier,Amelie Seguin,Miguel Hie,Alain Wynckel,Yahsou Delmas,Jean-Francois Augusto,Pierre Perez,Virginie Rieu,Christelle Barbet,Francois Lhote,Marc Ulrich,Anne Charvet Rumpler, Sten de Witte,Thierry Krummel,Agnes Veyradier,Ygal Benhamou Blood（2020）
AI 理解论文
溯源树
样例
